Screener
Aldeyra Therapeutics ALDX Q1 2026 earnings
Reported May 7, 2026 · After market close
EPS-$0.06Beat by $0.07
EPS estimate-$0.13
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.5M
EPS estimate-$0.11
Versus estimates
Diluted EPS
FAQ
- When did Aldeyra Therapeutics report Q1 2026 earnings?
- Aldeyra Therapeutics (ALDX) reported Q1 2026 earnings on May 7, 2026 after market close.
- What were Aldeyra Therapeutics's Q1 2026 revenue and EPS?
- Aldeyra Therapeutics reported eps of $-0.06 for Q1 2026.
- Did Aldeyra Therapeutics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.13 by $0.07.
- How did Aldeyra Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 64.7% from $-0.17.
- Where can I find Aldeyra Therapeutics's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001341235-26-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.
